Table 3. Clinical Data of CD171 Positive GIST Cases.
| Age | Sex | Primary Site | CD171 Expression | Genetic | Tumor Size | Mitosis | Risk | Follow-up Data | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Positivity (%) | Intensity | Profile | (cm) | (/50HPF) | Group | (month) | Outcome | |||
| 41 | F | Stomach | 100 | Moderate | SDH-deficient | 7.0 | 19 | 6a | 180 | AWM |
| 20 | F | Stomach | 100 | Weak | SDH-deficient | ND | 7 | - | ND | |
| 19 | M | Stomach | 100 | Weak | SDH-deficient | 4.5 | 12 | 5 | 132 | ANR |
| 70 | F | Stomach | 100 | Weak | KIT-Mutant Del 560 | 3.0 | 1 | 2 | 163 | DOC |
| 65 | F | Stomach | 100 | Weak | KIT-Mutant V559D | 5.0 | 0 | 2 | ND | |
| 55 | M | Stomach | 100 | Weak | KIT-Mutant Del 557-558 | 4.5 | 6 | 5 | 239 | DOC |
| 26 | M | Stomach | 100 | Weak | KIT-Mutant Delins 563-576I | 5.0 | 3 | 2 | 60 | ANR |
| 50 | M | Stomach | 100 | Weak | KIT/PDGFRA Wild Type | 5.0 | 6 | 5 | 32 | ANR |
| 70 | M | Stomach | 100 | Weak | ND | 7.5 | 0 | 3a | 152 | ANR |
| 66 | M | Stomach | 100 | Strong | ND | 7.0 | >100 | 6a | 5 | DOD |
| 62 | F | Stomach | 90 | Weak | PDGFRA-Mutant Delins 842-846E | 5.0 | 11 | 5 | 28 | DOC |
| 67 | M | Stomach | 80 | Weak | KIT/PDGFRA Wild Type | 4.5 | 0 | 2 | 116 | ANR |
| 32 | M | Stomach | 80 | Weak | ND | 12.0 | 3 | 3b | 158 | DOD |
| 53 | M | Stomach | 40 | Moderate | ND | 2.3 | 2 | 2 | 307 | ANR |
| 42 | M | Stomach | 10 | Weak | KIT-Mutant Delins 567-576 V | 6.0 | 1 | 3a | 201 | ANR |
| 67 | M | Duodenum | 100 | Weak | ND | 3.0 | >100 | - | 22 | DOD |
| 81 | F | Cecum | 20 | Weak | ND | ND | 10 | - | ND | |
| 32 | M | Colon | 10 | Weak | KIT/PDGFRA Wild Type | 6.0 | 2 | - | ND | |
| 62 | M | Colon | 60 | Strong | ND | 7.5 | >100 | - | ND | |
| 58 | M | Rectum | 80 | Moderate | ND | 0.8 | 44 | - | 203 | DUC |
GIST: gastrointestinal stromal tumor, ANR: alive with no recurrence, AWM: alive with metastasis, DOC: died of other cause, DOD: died of disease, DUC: died of unknown cause, ND: no data.